Clinical Trial Update: Imaging Immune Activation in HIV by PET-MR [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating imaging immune activation in HIV infections using PET-MR; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: CellSight Technologies, Inc. | Conditions: HIV Infections | Phase 2 | Status: RECRUITING